Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam vs propofol for colonoscopy sedation
CTR20180510Phase 3Completed
- Sponsor
- Yichang Humanwell Pharmaceutical Co., Ltd.
- Start
- Sep 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of remimazolam in procedural sedation and analgesia (PSA), sponsored by Yichang Humanwell Pharmaceutical Co., Ltd.. Started Sep 2018; status: completed.
02
Drugs
remimazolam
03
Conditions
procedural sedation and analgesia (PSA)
Beyond the preview
Go deeper on CTR20180510.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20180510.